drugset / Trial / NCT07606274
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
Non-randomizedSequentialOpen-labelOther
Summary
This study is designed to evaluate the safety and tolerability of NVC-001 in adults with LMNA-related dilated cardiomyopathy (LMNA-DCM). The study will also assess exploratory measures of efficacy.
Timeline
- Start
- 2026-06-16
- Primary completion
- 2030-03
- Completion
- 2030-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVC-001 | Gene therapy (AAV / viral vector) | — | Intravenous |